Sibutramine Hydrochloride Monohydrate is a compound formerly used as an appetite suppressant for obesity treatment. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases satiety by inhibiting the reuptake of neurotransmitters. However, it has been withdrawn from many markets due to cardiovascular safety concerns. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Sibutramine hydrochloride monohydrate, Reductil and Sibutramine hydrochloride hydrate. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 64765.
Meridia
| CAS No | 125494-59-9 |
|---|---|
| Molecular Formula | C17H29Cl2NO |
| Molecular Weight | 334.30 g/mol |
| Synonyms | 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine;hydrate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Sibutramine Hydrochloride Monohydrate is a compound formerly used as an appetite suppressant for obesity treatment. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases satiety by inhibiting the reuptake of neurotransmitters.
The listed CAS number is 125494-59-9.
The listed molecular formula is C17H29Cl2NO.
The listed molecular weight is 334.30 g/mol.
1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine;hydrate;hydrochloride.
The source lists Sibutramine hydrochloride monohydrate, Reductil and Sibutramine hydrochloride hydrate.